Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages

Alisa E. Koch, Steven L. Kunkel, Steven W. Chensue, G. Kenneth Haines, Robert M. Strieter

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Abstract

Interleukin-1 (IL-1) has protean effects in the pathogenesis of rheumatoid arthritis (RA). These effects include production of prostaglandins and collagenase from rheumatoid fibroblasts as well as upregulation of adhesion molecule expression on these cells. IL-1 can activate monocytes and neutrophils, as well as promote the growth of fibroblasts and endothelial cells. Recently, a novel interleukin-1 receptor antagonist protein (IRAP) has been isolated, purified, cloned, and expressed, which may modulate the effects of IL-1. In this study, we present data demonstrating that macrophages isolated from human RA synovial tissues express both IL-1 and IRAP genes. In addition, RA synovial tissue macrophages and lining cells display IL-1 and IRAP antigenic expression by immunohistochemistry. In contrast, osteoarthritis synovial tissues, as compared to RA, have fewer IL-1 and IRAP-positive macrophages. Thus, the production of IL-1 balanced by IRAP may affect the joint destruction found in these diseases.

Original languageEnglish
Pages (from-to)23-29
Number of pages7
JournalClinical Immunology and Immunopathology
Volume65
Issue number1
DOIs
StatePublished - Oct 1992
Externally publishedYes

Fingerprint

Dive into the research topics of 'Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages'. Together they form a unique fingerprint.

Cite this